stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Uniqure NvQURE
$24.831.86%-0.47
Dopo l'orario di chiusura: 26.50+1.67 +6.73%

Uniqure Nv (QURE)

Date: 2026-10-30 16:00O: 25.11H: 25.21L: 23.56C: 24.83Vol: 1.797M
Precedente Chiudi:
$25.30
Aprire:
$25.11
Volume 24 ore:
1,797,006
Volume relativo:
1.32
Capitalizzazione di mercato:
$1.72B
Reddito:
$18.09M
Utile/perdita netta:
-$208.87M
Rapporto P/E:
-
EPS:
-$3.51
Flusso di cassa netto:
-$178.15M
1W Prestazione:
+10.70%
1M Prestazione:
+2.77%
6M Prestazione:
+24.46%
1Y Prestazione:
-63.41%
Intervallo 1D:
$23.56$25.21
Intervallo di 1 settimana:
$21.45$25.99
Portata 52W:
$8.73$69.99

Profilo aziendale di Uniqure Nv (QURE)

Nome
Uniqure Nv
Settore
Healthcare
Industria
Biotechnology
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands
Dipendente
221
Prossima data di guadagno
2026-11-04
Ultimi documenti SEC
SEC
Discussioni di QURE su X
X

Confronta QURE con VRTX, REGN, MRNA, ARGX, ONC

AzioniPrezzoCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
QURE
Uniqure Nv
$24.83$1.72B$18.09M-$208.87M-$178.15M-$3.51
VRTX
Vertex Pharmaceuticals Inc
$558.88$141.65B$12.34B$4.34B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$927.89$95.53B$14.92B$4.42B$3.79B$41.04
MRNA
Moderna Inc
$221.72$88.52B$2.23B-$3.19B-$1.60B-$8.15
ARGX
Argen X Se Adr
$892.87$56.15B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$370.33$41.89B$5.76B$514.49M$1.10B$4.48

Uniqure Nv Azioni (QURE) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-05DowngradeBarclaysOverweight → Equal Weight
2026-09-02ResumedWilliam BlairOutperform
2026-07-30AggiornamentoWolfe ResearchPeer Perform → Outperform
2026-06-18AggiornamentoBarclaysEqual Weight → Overweight

Uniqure Nv Azioni (QURE) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Uniqure Nv Azioni (QURE) insider trading

  • Officer
    Transazione
    Proposed Sale
    Costo
    $45.15
    #Azioni
    21,082
    Valore ($)
    951,932
    #Azioni Totale
    0
  • CEO, Managing Director
    Transazione
    Sale
    Costo
    $45.16
    #Azioni
    21,082
    Valore ($)
    952,051
    #Azioni Totale
    519,227
  • Kaye JackJun 30 '26
    Director
    Transazione
    Option Exercise
    Costo
    $23.44
    #Azioni
    21,167
    Valore ($)
    496,230
    #Azioni Totale
    43,056
  • Kaye JackJun 30 '26
    Director
    Transazione
    Sale
    Costo
    $46.44
    #Azioni
    21,167
    Valore ($)
    983,030
    #Azioni Totale
    25,996
  • Abi-Saab WalidJun 30 '26
    Chief Medical Officer
    Transazione
    Option Exercise
    Costo
    $5.59
    #Azioni
    10,000
    Valore ($)
    55,900
    #Azioni Totale
    178,235
  • Abi-Saab WalidJun 30 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $46.42
    #Azioni
    30,000
    Valore ($)
    1,392,600
    #Azioni Totale
    148,235
  • Abi-Saab WalidJun 30 '26
    Chief Medical Officer
    Transazione
    Proposed Sale
    Costo
    $46.42
    #Azioni
    30,000
    Valore ($)
    1,392,643
    #Azioni Totale
    0
  • Kaye JackJun 30 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $46.44
    #Azioni
    21,167
    Valore ($)
    983,033
    #Azioni Totale
    0
  • Abi-Saab WalidJun 26 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $46.86
    #Azioni
    1,434
    Valore ($)
    67,197
    #Azioni Totale
    168,235
  • Abi-Saab WalidJun 26 '26
    Chief Medical Officer
    Transazione
    Proposed Sale
    Costo
    $46.86
    #Azioni
    1,434
    Valore ($)
    67,197
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Kapusta Matthew COfficerJul 02 '26Proposed Sale$45.1521,082951,9320
Kapusta Matthew CCEO, Managing DirectorJul 02 '26Sale$45.1621,082952,051519,227
Kaye JackDirectorJun 30 '26Option Exercise$23.4421,167496,23043,056
Kaye JackDirectorJun 30 '26Sale$46.4421,167983,03025,996
Abi-Saab WalidChief Medical OfficerJun 30 '26Option Exercise$5.5910,00055,900178,235
Abi-Saab WalidChief Medical OfficerJun 30 '26Sale$46.4230,0001,392,600148,235
Abi-Saab WalidChief Medical OfficerJun 30 '26Proposed Sale$46.4230,0001,392,6430
Kaye JackDirectorJun 30 '26Proposed Sale$46.4421,167983,0330
Abi-Saab WalidChief Medical OfficerJun 26 '26Sale$46.861,43467,197168,235
Abi-Saab WalidChief Medical OfficerJun 26 '26Proposed Sale$46.861,43467,1970

Uniqure Nv Borsa (QURE) Ultime notizie

Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 13, 2026
Oct 13, 2026
Oct 12, 2026
Oct 12, 2026
Oct 08, 2026
Oct 08, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 25, 2026
Sep 25, 2026
Sep 24, 2026
Sep 24, 2026
Sep 23, 2026
Sep 23, 2026
Sep 22, 2026
Sep 22, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 10, 2026
Sep 10, 2026

Simile a QURE